Tetra Bio-Pharma Inc. is developing cannabinoid-derived medicines using scientific validation and safety data that meet the requirements of the pharmaceutical industry.

The efficacy and safety of these new cannabinoid-derived drugs are tested in clinical trials before being approved by the regulatory authorities as safe and effective treatments for patients.